One of the better things the company did was to raise money when...

One of the better things the company did was to raise money when they did (1.30 from memory ).
Altho participants may not be that happy they have halved their dough .
Since then the share price and news has been pretty average.
In full disclosure I’ve sold some recently ( wasn’t going to but more for EOFY reasons ) .
As far as the FDA process goes I repeat I’m surprised that the company (at least yet) doesn’t seem to have been able to tell us where they will head now . Vision endpoints were well flagged in IXCs first FDA response .

I still hold a fair amount and may re add later once I see a clear pathway ahead